This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Draftfcb Acquires Hudson Global; Aligns It With Draftfcb Healthcare

NEW YORK, Sept. 12, 2012 /PRNewswire/ -- Draftfcb, the global marketing communications agency network that is part of the Interpublic Group (NYSE: IPG), is acquiring Hudson Global, a Tarrytown, N.Y.-based pharmaceutical marketing company that offers integrated marketing solutions encompassing the entire pharmaceutical brand management spectrum, and aligning it under its Draftfcb Healthcare umbrella. The merger will create a top 5 healthcare offering in the U.S.

"Our acquisition of Hudson is part of a long-term plan to make strategic acquisitions that will bolster our clients' businesses and strengthen our agency's offerings in those markets that offer the greatest opportunity," said Laurence Boschetto, global CEO and president of Draftfcb.

Hudson Global, with 55+ employees, includes among its core services: digital media and interactive marketing programs, peer-to-peer programming, consumer programming, medical strategy, and data and analytics services. It also has an important educational component that is aimed at professional healthcare, patient, and consumer audiences.

Since its founding in 2004, Hudson has provided solutions to sales and marketing teams at more than 30 pharma companies and represented more than 60 different pharmaceutical brands, which generate over $46 billion in annual sales. 

Hudson currently works with three types of clients: pharma, diagnostic and biotech.  It provides services to 20 major companies, including 15 of the largest pharma companies in the world.  The company also works with mid-tier pharma companies and medical device companies.  Hudson operates in a variety of therapeutic areas including oncology, cardiovascular, CNS, dermatology, diabetes, gastroenterology, infectious diseases, pediatrics, respiratory, rheumatology, women's health, and biologics.

Hudson will retain its name, and maintain its Tarrytown location. It will continue to be led by Robert Blink, co-founder and CEO/President of Hudson, and Jason Goldklang, co-founder and Executive Vice President. Blink will report directly to Draftfcb Healthcare and Draftfcb New York CEO Dana Maiman.



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs